Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

The Global Biomedical Industry: Preserving U.S. Leadership

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
206 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon
Ratings have been disabled for this video.

Uploaded by on Sep 21, 2011

The United States is still the global leader in the biomedical industry, but countries across Europe and Asia are pursuing aggressive plans to close the gap and take the high-value jobs and capital this sector creates. To protect its leadership position, U.S. policymakers need to take a series of actions.

The stakes are high: The biomedical sector directly and indirectly accounts for some 5 million U.S. jobs (including 1.2 million high-wage private-sector jobs in pharmaceuticals, biotech, medical devices, research and testing). Multiple factors leave the U.S. vulnerable to growing international competition: increasing complexity and uncertainty in the FDA's approval processes, especially as these relate to medical devices; government funding cuts; and federal tax policies that are not globally competitive.

European and Asian nations are investing heavily in research as well as improving access to capital for biotech start-ups. They are also taking a page from the U.S. playbook as they standardize their regulatory regimes and offer better incentives for innovation.

Beyond the established biopharmaceutical leaders in Europe and Japan, China, India and Singapore are making impressive strides in building their capacity for research, clinical testing and manufacturing. The world's best scientific talent traditionally flocked to the U.S., but today these highly prized knowledge workers are finding new job opportunities at home.

U.S. policymakers must take these seven decisive steps for the nation to retain its lead in biomedical innovation:


Increase R&D tax incentives and make them permanent

Cut corporate tax rates to match the OECD average

Enhance support for emerging fields

Provide adequate resources for the FDA and the NIH

Leverage existing strengths in medical devices

Build human capital

Promote and expand the role of universities



"The Global Biomedical Industry: Preserving U.S. Leadership" was funded in part by a grant from the Council for American Medical Innovation. The views expressed in the report are solely those of the Milken Institute.


The location of this report can be found here: http://www.milkeninstitute.org/publications/publications.taf?function=detail&...

Category:

Nonprofits & Activism

License:

Standard YouTube License

All Comments

Adding comments has been disabled for this video.

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more